GRIMAUD BRETT A. (SVP, GEN COUNSEL AND SECRETARY) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/22/2026ACC: 0001966698-26-000006
Officer· SVP, GEN COUNSEL AND SECRETARY
Since Feb 2026
-8.83K
Net shares
Net seller
$146.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.83K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−8.83K
Price / share
$16.55
Trade value
$146.12K
% of position
2.4%
5/20/2026
371.95K→363.12K
Total
Net shares
−8.83K
Net value
-$146.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/20/2026 | F · Tax Withholding | −8.83K | $16.55 | $146.12K | 2.4% | 371.95K | 363.12K |
| Total | −8.83K | -$146.12K | ||||||
Derivative Transactions0
No derivative transactions reported